CRIS
CRIS
NASDAQ · Biotechnology

Curis Inc

$0.83
+0.00 (+0.18%)
As of Sep 28, 10:39 PM ET ·
Financial Highlights (FY 2026)
Revenue
31.64M
Net Income
-25,402,811
Gross Margin
99.5%
Profit Margin
-80.3%
Rev Growth
-2.4%
D/E Ratio
—
Revenue & Net Income
Margin Trends
FY 2026 FY 2025 FY 2024 FY 2023
Gross Margin 99.5% 99.5% 41.3% 41.3%
Operating Margin -60.5% -54.4% -4.7% -4.5%
Profit Margin -80.3% -76.3% -4.3% -5.5%
Income Statement
FY 2026 FY 2025 FY 2024 FY 2023
Revenue 31.64M 32.42M 3.13M 3.55M
Gross Profit 31.49M 32.26M 1.30M 1.47M
Operating Income -19,140,931 -17,652,257 -147,597 -160,008
Net Income -25,402,811 -23,427,123 -134,676 -196,009
Gross Margin 99.5% 99.5% 41.3% 41.3%
Operating Margin -60.5% -54.4% -4.7% -4.5%
Profit Margin -80.3% -76.3% -4.3% -5.5%
Rev Growth -2.4% -2.4% +0.4% +3.6%
Balance Sheet
FY 2026 FY 2025 FY 2024 FY 2023
Total Debt 0 0 1.19M 1.49M
Total Equity — — 5.82M 5.64M
D/E Ratio — — 0.21 0.27
Cash Flow
FY 2026 FY 2025 FY 2024 FY 2023
EBITDA -18,574,729 -18,081,763 -218,349 -232,431
Free Cash Flow — — -122,296 -194,300